Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harold Helderman

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|December 26, 2001
Gastrointestinal complications of transplant immunosuppressionJ Harold Helderman, Simin Goral
Journal of the American Society of Nephrology : JASN|September 27, 2000
Cyclosporine avoidancePhilippe Gauthier, J Harold Helderman
Nature Clinical Practice. Nephrology|January 30, 2008
Do calcium channel blockers prevent delayed graft function after renal transplantation?Jeffrey A Giullian, J Harold Helderman
Nature Reviews. Nephrology|December 22, 2009
Contemporary dialysis: as good as transplantation?Heidi M Schaefer, J Harold Helderman
Journal of the American Society of Nephrology : JASN|January 16, 2010
Allograft nephrectomy after transplant failure: should it be performed in all patients returning to dialysis?Heidi M Schaefer, J Harold Helderman
Kidney International|July 12, 2002
Identifying and addressing potentially preventable causes of renal allograft lossAnthony J Langone, J Harold Helderman
The New England Journal of Medicine|August 15, 2003
Disparity between solid-organ supply and demandAnthony J Langone, J Harold Helderman
Chest|September 6, 2012
Mammalian target of rapamycin inhibitors in organ transplantation: an unkept promiseAnthony J Langone, J Harold Helderman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 25, 2006
Slow decline in allograft function in a renal transplant patientHeidi M Schaefer, J Harold Helderman, Agnes B Fogo
Applied Health Economics and Health Policy|December 30, 2009
Healthcare costs in renal transplant recipients using branded versus generic ciclosporinJ Harold Helderman, Ning Kang, Antonio P Legorreta, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|December 26, 2001
Gastrointestinal complications of transplant immunosuppressionJ Harold Helderman, Simin Goral
Journal of the American Society of Nephrology : JASN|September 27, 2000
Cyclosporine avoidancePhilippe Gauthier, J Harold Helderman
Nature Clinical Practice. Nephrology|January 30, 2008
Do calcium channel blockers prevent delayed graft function after renal transplantation?Jeffrey A Giullian, J Harold Helderman
Nature Reviews. Nephrology|December 22, 2009
Contemporary dialysis: as good as transplantation?Heidi M Schaefer, J Harold Helderman
Journal of the American Society of Nephrology : JASN|January 16, 2010
Allograft nephrectomy after transplant failure: should it be performed in all patients returning to dialysis?Heidi M Schaefer, J Harold Helderman
Kidney International|July 12, 2002
Identifying and addressing potentially preventable causes of renal allograft lossAnthony J Langone, J Harold Helderman
The New England Journal of Medicine|August 15, 2003
Disparity between solid-organ supply and demandAnthony J Langone, J Harold Helderman
Chest|September 6, 2012
Mammalian target of rapamycin inhibitors in organ transplantation: an unkept promiseAnthony J Langone, J Harold Helderman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 25, 2006
Slow decline in allograft function in a renal transplant patientHeidi M Schaefer, J Harold Helderman, Agnes B Fogo
Applied Health Economics and Health Policy|December 30, 2009
Healthcare costs in renal transplant recipients using branded versus generic ciclosporinJ Harold Helderman, Ning Kang, Antonio P Legorreta, et al.
Pageof 4